Semaglutide vs. Tirzepitide: Which Obesity Drug Could Be Your Game Changer Part 1
Send us a text
Resources for the Community:
____________________________________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
____________________________________________________________________________________________
Part 1
This episode delves into the intricate relationship between insulin resistance, polycystic ovarian syndrome (PCOS), and obesity. We explore how these conditions often intertwine, leading to a cyclical pattern that can be challenging to break.
We discuss the fascinating study of adipose tissue's remarkable ability to remember past weight gain, even after significant weight loss. This phenomenon sheds light on the persistent challenges faced by individuals who have lost weight and are striving to maintain their progress.
We also delve into the critical role of basal metabolic rate (BMR) and caloric consumption in weight management. Understanding these factors can empower individuals to make informed choices about their diet and exercise routines.
Finally, we compare and contrast two groundbreaking medications, semaglutide and tirzepitide. Both drugs have shown remarkable efficacy in treating obesity, but there are key differences in their mechanisms of action and potential side effects. We explore the latest research to determine which medication may be the best fit for different individuals.
____________________________________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
____________________________________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
Support the show
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
Information
- Show
- FrequencyUpdated Weekly
- PublishedDecember 17, 2024 at 2:00 PM UTC
- Length35 min
- Season4
- Episode14
- RatingClean